Automated Molecular PCR Platform
Estimated value
£404k
Awarded value
£338k
Suppliers
1
Lots
1
Published
18 Feb 2026
Description
In May 2023, universal, post-donation screening for HHV-8 antibodies was added to the portfolio of tests required for deceased organ donor characterisation in the UK. Routine pre-donation testing for other required infection markers continue to be performed on an urgent 24/7 basis by a network of UK wide NHS diagnostic laboratories. MSL Virology require a fully automated platform to perform testing for HHV8 DNA in plasma and whole blood samples. MSL Virology also requires a fully automated platform to perform testing for CMV DNA, HEV RNA and HBV DNA in EDTA plasma samples.
Scope
- Reference
- CF-3393400D0O000000rwimUAA
- Total value
- £404,382.6 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Dec 2025 to 30 Nov 2028
- CPV classifications
- 38000000
Submission & procedure
- Submission deadline
- 03 Nov 2025, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£338k
Award date
18 Feb 2026
Contract start
01 Dec 2025
Contract end
30 Nov 2028